BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2062460)

  • 1. Regional distribution of the two subtypes of angiotensin II receptor in rat brain using selective nonpeptide antagonists.
    Leung KH; Smith RD; Pieter ; Timmermans BM; Chiu AT
    Neurosci Lett; 1991 Feb; 123(1):95-8. PubMed ID: 2062460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2).
    Wong PC; Hart SD; Zaspel AM; Chiu AT; Ardecky RJ; Smith RD; Timmermans PB
    J Pharmacol Exp Ther; 1990 Nov; 255(2):584-92. PubMed ID: 2243344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrimination of angiotensin II receptor subtype distribution in the rat brain using non-peptidic receptor antagonists.
    Rowe BP; Grove KL; Saylor DL; Speth RC
    Regul Pept; 1991 Mar; 33(1):45-53. PubMed ID: 2047544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-peptide angiotensin II receptor antagonists discriminate subtypes of 125I-angiotensin II binding sites in the rat brain.
    Gehlert DR; Gackenheimer SL; Reel JK; Lin HS; Steinberg MI
    Eur J Pharmacol; 1990 Oct; 187(1):123-6. PubMed ID: 2272349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II receptor subtypes are coupled with distinct signal-transduction mechanisms in neurons and astrocytes from rat brain.
    Sumners C; Tang W; Zelezna B; Raizada MK
    Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7567-71. PubMed ID: 1881896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different types of receptor interaction of peptide and nonpeptide angiotensin II antagonists revealed by receptor binding and functional studies.
    Wienen W; Mauz AB; Van Meel JC; Entzeroth M
    Mol Pharmacol; 1992 Jun; 41(6):1081-8. PubMed ID: 1614410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II stimulates phosphoinositide turnover and phosphorylase through AII-1 receptors in isolated rat hepatocytes.
    García-Sáinz JA; Macías-Silva M
    Biochem Biophys Res Commun; 1990 Oct; 172(2):780-5. PubMed ID: 2173579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II receptor subtypes in renal cortex of rats and rhesus monkeys.
    Gibson RE; Thorpe HH; Cartwright ME; Frank JD; Schorn TW; Bunting PB; Siegl PK
    Am J Physiol; 1991 Sep; 261(3 Pt 2):F512-8. PubMed ID: 1653532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping of angiotensin II receptor subtype heterogeneity in rat brain.
    Song K; Allen AM; Paxinos G; Mendelsohn FA
    J Comp Neurol; 1992 Feb; 316(4):467-84. PubMed ID: 1577995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II receptor subtypes in rat brain: dithiothreitol inhibits ligand binding to AII-1 and enhances binding to AII-2.
    Gehlert DR; Gackenheimer SL; Schober DA
    Brain Res; 1991 Apr; 546(1):161-5. PubMed ID: 1855146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H]DUP 753, a highly potent and specific radioligand for the angiotensin II-1 receptor subtype.
    Chiu AT; McCall DE; Aldrich PE; Timmermans PB
    Biochem Biophys Res Commun; 1990 Nov; 172(3):1195-202. PubMed ID: 2244903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DuP 753 can antagonize the effects of angiotensin II in rat liver.
    Bauer PH; Chiu AT; Garrison JC
    Mol Pharmacol; 1991 Apr; 39(4):579-85. PubMed ID: 2017158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II receptor recognized by DuP753 regulates two distinct guanine nucleotide-binding protein signaling pathways.
    Crawford KW; Frey EA; Cote TE
    Mol Pharmacol; 1992 Jan; 41(1):154-62. PubMed ID: 1310139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DuP 532: a second generation of nonpeptide angiotensin II receptor antagonists.
    Chiu AT; Carini DJ; Duncia JV; Leung KH; McCall DE; Price WA; Wong PC; Smith RD; Wexler RR; Timmermans PB
    Biochem Biophys Res Commun; 1991 May; 177(1):209-17. PubMed ID: 2043107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of distinct angiotensin II binding sites in rat adrenal gland and bovine cerebellum using selective nonpeptide antagonists.
    Wiest SA; Rampersaud A; Zimmerman K; Steinberg MI
    J Cardiovasc Pharmacol; 1991 Feb; 17(2):177-84. PubMed ID: 1709220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of angiotensin II receptor subtypes in individual rat brain nuclei.
    Rowe BP; Saylor DL; Speth RC
    Neuroendocrinology; 1992 May; 55(5):563-73. PubMed ID: 1584339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of renal angiotensin II receptors using subtype selective antagonists.
    Edwards RM; Stack EJ; Weidley EF; Aiyar N; Keenan RM; Hill DT; Weinstock J
    J Pharmacol Exp Ther; 1992 Mar; 260(3):933-8. PubMed ID: 1545405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for the presence of angiotensin II-type 1 receptors in brain.
    Wamsley JK; Herblin WF; Alburges ME; Hunt M
    Brain Res Bull; 1990 Sep; 25(3):397-400. PubMed ID: 2292036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of inhibitory potency by nonpeptide angiotensin II receptor antagonists PD123177 and DuP 753 on proximal nephron and renal transport.
    Cogan MG; Liu FY; Wong PC; Timmermans PB
    J Pharmacol Exp Ther; 1991 Nov; 259(2):687-91. PubMed ID: 1941617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential development of angiotensin II receptor subtypes in the rat brain.
    Tsutsumi K; Saavedra JM
    Endocrinology; 1991 Jan; 128(1):630-2. PubMed ID: 1986946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.